Global Global Antimalarial Drugs Market Research Report 2022-2028 Featuring Cipla, GSK, Ipca, Merck, Novartis, Zydus Cadila, Sun Pharma, Strides Pharma, Glenmark Pharma, Lincoln Pharma

DUBLIN, Feb. 17, 2023 /PRNewswire/ -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By Route of Administration, By Malaria Type, By Application, By Distribution Channel, By Region, Forecast & Opportunities, 2028" report has been added to  ResearchAndMarkets.com's offering.

Global antimalarial drugs market is expected to register impressive growth during the forecast period, 2024-2028

Increasing prevalence of malaria coupled with surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the "World Malaria Report 2021" by World Health Organization (WHO), in 2020, there were approximately 228 million cases and about 6,02,000 malaria-related deaths.

Moreover, the increase in awareness initiatives by governments is also a key factor for growth of antimalarial drugs market. In 2021, the government of Malawi launched a 'Zero Malaria Starts with Me' campaign to stop malaria by the year 2030, which is the leading cause of death in Malawi.

Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market. According to World Health Organization (WHO), about half of the world's population is at risk of malaria.

Global antimalarial drugs market can be segmented based on drug type, drug class, route of administration, malaria type, application, distribution channel, company, and region. Based on drug class, the market is segmented into aryl aminoalcohol compounds, antifolate compounds, artemisinin compounds and antimicrobials. Among them, the aryl aminoalcohol compounds segment is expected to witness high growth during the forecast period owing to rising cases of malaria across the world.

Based on route of administration, the global antimalarial drugs market is segmented into oral, powder inhalation and intravenous administration. Among them, the oral segment is expected to undergo high growth through 2028 owing to the advantages such as safety, easy ingestion, pain avoidance and better patient compliance.

Major players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.

Objective of the Study:

• To analyze and forecast the market size of global antimalarial drugs market.
• To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.
• To identify drivers and challenges for global antimalarial drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.
• To identify and analyse the profile of leading players operating in the global antimalarial drugs market.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global antimalarial drugs market.

• Cipla Ltd
• GlaxoSmithKline Plc
• Ipca Laboratories Ltd.
• Merck & Co., Inc
• Novartis AG
• Zydus Cadila
• Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
• Strides Pharma Science Limited
• Glenmark Pharmaceuticals Ltd.
• Lincoln Pharmaceuticals Ltd.

Report Scope:

Global Antimalarial Drugs Market, By Drug Type:

• Quinine
• Chloroquine
• Proguanil
• Amodiaquine
• Mefloquine
• Hydroxychloroquine
• Pyrimethamine
• Others

Global Antimalarial Drugs Market, By Drug Class:

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds
• Antimicrobials

Global Antimalarial Drugs Market, By Route of Administration:

• Oral
• Powder Inhalation
• Intravenous Administration

Global Antimalarial Drugs Market, By Malaria Type:

• Plasmodium Falciparum
• Plasmodium Malariae
• Plasmodium Vivax
• Plasmodium Ovale
• Plasmodium Knowlesi

Global Antimalarial Drugs Market, By Application:

• Prevention
• Treatment of Malaria

Global Antimalarial Drugs Market, By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce
• Others

Global Antimalarial Drugs Market, By Region:

• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Singapore
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• North America
• United States
• Mexico
• Canada
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

For more information about this report visit https://www.researchandmarkets.com/r/yqlngt

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716 

Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg 

SOURCE Research and Markets